BILL · 2021–22 SESSION

SB 5822: Biomarker testing coverage

Concerning insurance coverage for biomarker testing.

Summary

  • Requires insurance coverage for biomarker testing when supported by medical and scientific evidence.

From the Senate Bill Report (Orig.) (SB 5822), written by the Legislature's nonpartisan staff. Read the full report ↗

Did not pass Did not pass · died in committee
  1. IntroducedJan 12, 2022
  2. Out of committeestopped here
  3. Passed Senate
  4. Passed House
  5. Governor
  6. Law
Prime sponsor
Lynda Wilson (R-17)
Introduced
January 12, 2022 in the Senate
Last action
January 12, 2022
Budget
Has a fiscal note

AN ACT Relating to insurance coverage for biomarker testing;

Sponsors

Votes

No recorded floor votes. This measure never reached a floor vote.

History

  1. First reading, referred to Health & Long Term Care.

SB 5822 in other sessions

Bill numbers restart every two years, so the same number is a different bill in each session.

Report wrong or missing information on this page